Emerging drugs for treatment of anemia of chronic kidney disease.

about

New renal anemia drugs: is there really anything new on the horizon?

P2860

Q44405723-621D61AC-EF53-48FD-A36B-ADA409C68A7F

P2860

Emerging drugs for treatment of anemia of chronic kidney disease.

Item

http://www.wikidata.org/entity/Q38137205

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Emerging drugs for treatment of anemia of chronic kidney disease.

@en

type

Item

label

Emerging drugs for treatment of anemia of chronic kidney disease.

@en

prefLabel

Emerging drugs for treatment of anemia of chronic kidney disease.

@en

P1476

Emerging drugs for treatment of anemia of chronic kidney disease.

@en

P2093

Akida Lebby

http://www.w3.org/2001/XMLSchema#string

Brian Chen

http://www.w3.org/2001/XMLSchema#string

Charles L Bennett

http://www.w3.org/2001/XMLSchema#string

Jametta S Magwood

http://www.w3.org/2001/XMLSchema#string

Sam Kessler

http://www.w3.org/2001/XMLSchema#string

P2860

Hypoxic regulation of erythropoiesis and iron metabolism

Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update.

Interpretation and review of health-related quality of life data in CKD patients receiving treatment for anemia.

Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes.

American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer.

Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease.

Peginesatide in patients with anemia undergoing hemodialysis.

Peginesatide for anemia in patients with chronic kidney disease not receiving dialysis.

Hypoxia inducible factor stabilization as a novel strategy to treat anemia.

Profile of peginesatide and its potential for the treatment of anemia in adults with chronic kidney disease who are on dialysis.

P304

421-429

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14728214.2013.836490

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Leann Norris

P577

2013-09-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256607955

http://www.w3.org/2001/XMLSchema#string

P698

24033253

http://www.w3.org/2001/XMLSchema#string

Emerging drugs for treatment of anemia of chronic kidney disease.

about

P2860

P2860

Emerging drugs for treatment of anemia of chronic kidney disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698